Institutional members access full text with Ovid®

Share this article on:

European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes

Jordan, Jensa; Schlaich, Markusb; Redon, Josepc; Narkiewicz, Krzysztofd; Luft, Friedrich Ce; Grassi, Guidof; Dixon, Johnb; Lambert, Gavinb; Engeli, Stefanafor the European Society of Hypertension Working Group on Obesity and the Australian and New Zealand Obesity Society

doi: 10.1097/HJH.0b013e3283427c8b
Editorial

aInstitute for Clinical Pharmacology, Medical School Hannover, Hannover, Germany

bBaker IDI Heart & Diabetes Institute, Melbourne, Australia

cINCLIVA, Research Institute, University of Valencia and CIBERobn Carlos III Institute, Madrid, Spain

dDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland

eExperimental and Clinical Research Center, Medical Faculty of the Charité, Berlin, Germany

fClinica Medica, University of Milano-Bicocca, Ospedale San Gerardo, Monza, Milan, Italy

Correspondence to Professor Jens Jordan, Chairman Working Group on Obesity, Institute of Clinical Pharmacology, Medical School Hannover, Carl-Neuberg-Straße 1, 30625 Hannover, Germany E-Mail: jordan.jens@mh-hannover.de, www.mh-hannover.de/klinpharm.html

© 2011 Lippincott Williams & Wilkins, Inc.